Abstract:Metabolic reprogramming, a hallmark of cancer, allows cancer cells to adapt to their specific energy needs. The Warburg effect benefits cancer cells in both hypoxic and normoxic conditions and is a well-studied reprogramming of metabolism in cancer. Interestingly, the alteration of other metabolic pathways, especially lipid metabolism has also grabbed the attention of scientists worldwide. Lipids, primarily consisting of fatty acids, phospholipids and cholesterol, play essential roles as structural component of cell membrane, signalling molecule and energy reserves. This reprogramming primarily involves aberrations in the uptake, synthesis and breakdown of lipids, thereby contributing to the survival, proliferation, invasion, migration and metastasis of cancer cells. The development of resistance to the existing treatment modalities poses a major challenge in the field of cancer therapy. Also, the plasticity of tumor cells was reported to be a contributing factor for the development of resistance. A number of studies implicated that dysregulated lipid metabolism contributes to tumor cell plasticity and associated drug resistance. Therefore, it is important to understand the intricate reprogramming of lipid metabolism in cancer cells. In this review, we mainly focused on the implication of disturbed lipid metabolic events on inducing tumor cell plasticity-mediated drug resistance. In addition, we also discussed the concept of lipid peroxidation and its crucial role in phenotypic switching and resistance to ferroptosis in cancer cells. Elucidating the relationship between lipid metabolism, tumor cell plasticity and emergence of resistance will open new opportunities to develop innovative strategies and combinatorial approaches for the treatment of cancer.

Lipid Metabolic Reprogramming in Tumor Microenvironment: from Mechanisms to Therapeutics

Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer and metastasis

Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy

Lipid metabolism in tumor microenvironment: novel therapeutic targets

Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer

Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives

Lipid Metabolism in Cancer Progression and Therapeutic Strategies

Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy

Targeting dysregulated lipid metabolism in the tumor microenvironment

Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment

Posttranslational Control of Lipogenesis in the Tumor Microenvironment

Lipid-mediated regulation of the cancer-immune crosstalk

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Lipids in the tumor microenvironment: From cancer progression to treatment

A Novel Insight into Cancer Therapy: Lipid Metabolism in Tumor-Associated Macrophages

Contradictory roles of lipid metabolism in immune response within the tumor microenvironment

Lipid metabolic reprogramming in cancer cells

Lipid Metabolism Reprogramming and Its Potential Targets in Cancer

Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?